reference/36624084

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36624084

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	409
issn	1759-7714 1759-7706
issueIdentifier	5
pageRange	402-409
publicationName	Thoracic Cancer
startingPage	402
bibliographicCitation	Kiritani A, Amino Y, Uchibori K, Akita T, Harutani Y, Ogusu S, Tsugitomi R, Manabe R, Ariyasu R, Kitazono S, Yanagitani N, Nishio M. Efficacy of osimertinib in patients with EGFR‐mutation positive non‐small cell lung cancer with malignant pleural effusion. Thoracic Cancer. 2024 Jan 16;15(5):402–9. doi: 10.1111/1759-7714.15210.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69f7c83d096dc031edd392cdde4e6de6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aeea611e768f1e975c42bd7c0538c060 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4393-9176 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b8a6151c98066d02943deddac8e3901 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e28b92c9ce7dde773f76e720b8aea720 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1491-923X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03ad1cd2a084099ec5ab070d1d1ca878 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4969-4165 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7a670af3ba6f29563cb887799569da8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3242-0662 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f2bad091aebcd89f714950b8fbf9a13 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04a5ba8847654400e30e0bf4015c5b01
date	2024-01-16^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC10864115 https://doi.org/10.1111/1759-7714.15210 https://pubmed.ncbi.nlm.nih.gov/38226415
isPartOf	https://portal.issn.org/resource/ISSN/1759-7706 https://portal.issn.org/resource/ISSN/1759-7714 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43270
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Efficacy of osimertinib in patients with EGFR‐mutation positive non‐small cell lung cancer with malignant pleural effusion
discusses	http://id.nlm.nih.gov/mesh/M0000268 http://id.nlm.nih.gov/mesh/M0011238 http://id.nlm.nih.gov/mesh/M000603988 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0500817 http://id.nlm.nih.gov/mesh/M0001215 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0018260
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007211 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D002289Q000235 http://id.nlm.nih.gov/mesh/D008175Q000235 http://id.nlm.nih.gov/mesh/D016066Q000235 http://id.nlm.nih.gov/mesh/D000178 http://id.nlm.nih.gov/mesh/D000814 http://id.nlm.nih.gov/mesh/D016066Q000188 http://id.nlm.nih.gov/mesh/D011743 http://id.nlm.nih.gov/mesh/D008175Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D066246Q000235 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D009364 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D047428

Showing number of triples: 1 to 56 of 56.